Eyenovia Inc., a leader in ophthalmic technologies, has announced a new partnership with Kinetiq, a prominent liquid staking protocol. The collaboration has resulted in the creation of the co-branded "Kinetiq x Hyperion" validator, which provides a premier liquid staking solution for institutional HYPE token holders within the Hyperliquid ecosystem. This strategic initiative marks Eyenovia's active engagement with ecosystem projects, leveraging its recent acquisition of over one million HYPE tokens to enhance network stability and security. Supported by Pier Two's advanced infrastructure, the partnership aims to foster secure and integrated liquid staking on Hyperliquid, positioning Eyenovia as a unique bridge between public markets and the onchain economy.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。